Publications Toxicology

Custodio RJP, Hobloss Z, Myllys M, Hassan R, González D, Reinders J, Bornhorst J, Weishaupt AK, Seddek AL, Abbas T, Friebel A, Hoehme S, Getzmann S, Hengstler JG, van Thriel C, Ghallab A:

Cognitive functions, neurotransmitter alterations, and hippocampal microstructural changes in mice caused by feeding on western diet. Cells 12 (18): 2331 (2023) (20 pp)

Wollin KM, Batke M, Damm G, Freyberger A, Gundert-Remy U, Mangerich A, Hengstler JG, Partosch F, Schupp T, Sonnenburg A, Foth H:

PFASs-restriction proposal commentary on ECHA's Annex XV restriction report, proposal for a restriction, March 2023. (Guest editorial). Arch Toxicol 97: 3305-3312 (2023)

Gerdemann A, Cramer B, Degen GH, Veerkamp J, Günther G, Albrecht W, Behrens M, Esselen M, Ghallab A, Hengstler JG, Humpf HU:

Comparative metabolism of aflatoxin B1 in mouse, rat and human primary hepatocytes using HPLC-MS/MS. Arch Toxicol 97: 3179-3196 (2023)

Kappenberg F, Duda JC, Schürmeyer L, Gül O, Brecklinghaus T, Hengstler JG, Schorning K, Rahnenführer J:

Guidance for statistical design and analysis of toxicological dose-response experiments, based on a comprehensive literature review. Arch Toxicol 97: 2741-2761 (2023)

Cherianidou A, Kappenberg F, Seidel F, Acharya A, Papazoglou P, Srinivasan SP, Hescheler J, Peng L, Leist M, Hengstler JG, Rahnenführer J, Sachinidis A:

Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells. Cell Death Discov 9 (1): 321 (2023) (12 pp)

Seidel F, Kappenberg F, Fayyaz S, Scholtz-Illigens A, Cherianidou A, Derksen K, Nell P, Marchan R, Edlund K, Leist M, Sachinidis A, Rahnenführer J, Kreiling R, Hengstler JG:

Risk assessment of parabens in a transcriptomics-based in vitro test. Chem Biol Interact 384: 110699 (2023)

Abdelmageed N, Twafik WA, Morad OA, Haridy M, Hassan R, Ahmed M, El-Zorba HY, El-Banna HA, Seddek AL, Ghallab A, Morad SAF:

Vinpocetine protects against chloroquine-induced cardiotoxicity by mitigating oxidative stress. Arch Toxicol 97: 2763–2770 (2023)

Kadhum T, Selinski S, Blaszkewicz M, Reinders J, Roth E, Volkert F, Ovsiannikov D, Moormann O, Gerullis H, Barski D, Otto T, Höhne S, Hengstler JG, Golka K:

Bladder cancer course, four genetic high-risk variants, and histopathological findings. EXCLI J 22: 867-879 (2023)

Krämer HH, Bücker P, Jeibmann A, Richter H, Rosenbohm A, Jeske J, Baka P, Geber C, Wassenberg M, Fangerau T, Karst U, Schänzer A, van Thriel C:

Gadolinium contrast agents: dermal deposits and potential effects on epidermal small nerve fibers. J Neurol 270: 3981-3991 (2023)

Drasdo D, Zhao J:

An integrative experimental and computational twin modeling approach to understand clonal dynamics in the normal liver. J Hepatol 79: 273-276 (2023)

Su H, Haque M, Becker S, Edlund K, Duda J, Wang Q, Reißing J, Marschall HU, Candels LS, Mohamed M, Sjöland W, Liao L, Drexler SA, Strowig T, Rahnenführer J, Hengstler JG, Hatting M, Trautwein C:

Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals. Liver Int 43: 1699-1713 (2023)

Duydu Y, Başaran N, Bolt HM:

What can we learn from epidemiological studies on chronic boron exposure? Crit Rev Toxicol 53: 168-180 (2023)

Maji RK, Czepukojc B, Scherer M, Tierling S, Cadenas C, Gianmoena K, Gasparoni N, Nordström K, Gasparoni G, Laggai S, Yang X, Sinha A, Ebert P, Falk-Paulsen M, Kinkley S, Hoppstädter J, Chung HR, Rosenstiel P, Hengstler JG, Walter J, Schulz MH, Kessler SM, Kiemer AK:

Alterations in the hepatocyte epigenetic landscape in steatosis. Epigenetics Chromatin 16 (1): 30 (2023) (14 pp)

Hammad S, Ogris C, Othman A, Erdoesi P, Schmidt-Heck W, Biermayer I, Helm B, Gao Y, Piorońska W, Holland CH, D'Alessandro LA, de la Torre C, Sticht C, Al Aoua S, Theis FJ, Bantel H, Ebert MP, Klingmüller U, Hengstler JG, Dooley S, Mueller NS:

Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation. Cell Death Dis 14 (7): 414 (2023) (13 pp)

Vucur M, Ghallab A, Schneider AT, Adili A, Cheng M, Castoldi M, Singer MT, Büttner V, Keysberg LS, Küsgens L, Kohlhepp M, Görg B, Gallage S, Barragan Avila JE, Unger K, Kordes C, Leblond AL, Albrecht W, Loosen SH, Lohr C, Jördens MS, Babler A, Hayat S, Schumacher D, Koenen MT, Govaere O, Boekschoten MV, Jörs S, Villacorta-Martin C, Mazzaferro V, Llovet JM, Weiskirchen R, Kather JN, Starlinger P, Trauner M, Luedde M, Heij LR, Neumann UP, Keitel V, Bode JG, Schneider RK, Tacke F, Levkau B, Lammers T, Fluegen G, Alexandrov T, Collins AL, Nelson G, Oakley F, Mann DA, Roderburg C, Longerich T, Weber A, Villanueva A, Samson AL, Murphy JM, Kramann R, Geisler F, Costa IG, Hengstler JG, Heikenwalder M, Luedde T:

Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56: 1578-1595.e8 (2023)